An innovative strategy to reduce the risk of type 2 diabetes and other obesity-related disorders including hepatic steatosis may exist thanks to a peptide (small protein) called PEPITEM, according to recent research (fatty liver).
According to new research, a peptide (small protein) called PEPITEM could provide a game-changing approach to lowering the risk of type 2 diabetes and other obesity-related diseases like hepatic steatosis (fatty liver).
Collaborative research between University of Galway and Brunel University London has found that patients with severe and complicated obesity respond differently to a dietary weight loss programme based on their genes.
Researchers have long been working on how to treat obesity, a serious condition that can lead to hypertension, diabetes, chronic inflammation, and cardiovascular diseases. Studies have also revealed a strong correlation between obesity and cancer, recent data show that smoking, drinking alco